Centro de Investigación de Medicina Aplicada (CIMA)
Centro / Instituto vinculado a la Universidad de Navarra
Helsinki University Central Hospital
Helsinki, FinlandiaPublicaciones en colaboración con investigadores/as de Helsinki University Central Hospital (6)
2022
-
Germline ERCC excision repair 6 like 2 (ERCC6L2) mutations lead to impaired erythropoiesis and reshaping of the bone marrow microenvironment
British Journal of Haematology, Vol. 199, Núm. 5, pp. 754-764
2021
-
Glucose-Dependent Insulinotropic Peptide in the High-Normal Range Is Associated With Increased Carotid Intima-Media Thickness
Diabetes care, Vol. 44, Núm. 1, pp. 224-230
-
Isatuximab as monotherapy and combined with dexamethasone in patients with relapsed/refractory multiple myeloma
Blood, Vol. 137, Núm. 9, pp. 1154-1165
2020
-
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Journal for ImmunoTherapy of Cancer, Vol. 8, Núm. 1
2016
-
Intrinsic resistance to PIM kinase inhibition in AML through p38α-mediated feedback activation of mTOR signaling
Oncotarget, Vol. 7, Núm. 25, pp. 37407-37419
2010
-
Human adenovirus replication in immunocompetent Syrian hamsters can be attenuated with chlorpromazine or cidofovir
Journal of Gene Medicine, Vol. 12, Núm. 5, pp. 435-445